These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 28189343)

  • 1. Early upregulation of 18-kDa translocator protein in response to acute neurodegenerative damage in TREM2-deficient mice.
    Belloli S; Pannese M; Buonsanti C; Maiorino C; Di Grigoli G; Carpinelli A; Monterisi C; Moresco RM; Panina-Bordignon P
    Neurobiol Aging; 2017 May; 53():159-168. PubMed ID: 28189343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-3473b regulates the expression of TREM2/ULK1 and inhibits autophagy in inflammatory pathogenesis of Parkinson disease.
    Lv Q; Zhong Z; Hu B; Yan S; Yan Y; Zhang J; Shi T; Jiang L; Li W; Huang W
    J Neurochem; 2021 May; 157(3):599-610. PubMed ID: 33448372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TREM2 modulates microglia phenotypes in the neuroinflammation of Parkinson's disease.
    Zhang Y; Feng S; Nie K; Li Y; Gao Y; Gan R; Wang L; Li B; Sun X; Wang L; Zhang Y
    Biochem Biophys Res Commun; 2018 May; 499(4):797-802. PubMed ID: 29621548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TREM2 overexpression attenuates neuroinflammation and protects dopaminergic neurons in experimental models of Parkinson's disease.
    Ren M; Guo Y; Wei X; Yan S; Qin Y; Zhang X; Jiang F; Lou H
    Exp Neurol; 2018 Apr; 302():205-213. PubMed ID: 29407460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Silencing of TREM2 exacerbates tau pathology, neurodegenerative changes, and spatial learning deficits in P301S tau transgenic mice.
    Jiang T; Tan L; Zhu XC; Zhou JS; Cao L; Tan MS; Wang HF; Chen Q; Zhang YD; Yu JT
    Neurobiol Aging; 2015 Dec; 36(12):3176-3186. PubMed ID: 26364736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microglial response in triggering receptor expressed on myeloid cells 2 (TREM2) knock-out mice after systemic stimulation with Escherichia coli.
    Hoogland ICM; Yik J; Westhoff D; Engelen-Lee JY; Valls Seron M; Man WK; Houben-Weerts JHPM; Tanck MW; van Westerloo DJ; van der Poll T; van Gool WA; van de Beek D
    Neurosci Lett; 2022 Nov; 790():136894. PubMed ID: 36183964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Injury-stimulated Sonic hedgehog expression in microglia contributes to neuroinflammatory response in the MPTP model of Parkinson's disease.
    Lee JH; Chung YC; Bok E; Lee H; Huh SH; Lee JE; Jin BK; Ko HW
    Biochem Biophys Res Commun; 2017 Jan; 482(4):980-986. PubMed ID: 27899315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Upregulation of TREM2 Ameliorates Neuroinflammatory Responses and Improves Cognitive Deficits Triggered by Surgical Trauma in Appswe/PS1dE9 Mice.
    Jiang Y; Li Z; Ma H; Cao X; Liu F; Tian A; Sun X; Li X; Wang J
    Cell Physiol Biochem; 2018; 46(4):1398-1411. PubMed ID: 29689568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TREM2 deficiency aggravates α-synuclein-induced neurodegeneration and neuroinflammation in Parkinson's disease models.
    Guo Y; Wei X; Yan H; Qin Y; Yan S; Liu J; Zhao Y; Jiang F; Lou H
    FASEB J; 2019 Nov; 33(11):12164-12174. PubMed ID: 31370707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disease Progression-Dependent Effects of TREM2 Deficiency in a Mouse Model of Alzheimer's Disease.
    Jay TR; Hirsch AM; Broihier ML; Miller CM; Neilson LE; Ransohoff RM; Lamb BT; Landreth GE
    J Neurosci; 2017 Jan; 37(3):637-647. PubMed ID: 28100745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. THY-Tau22 mouse model accumulates more tauopathy at late stage of the disease in response to microglia deactivation through TREM2 deficiency.
    Vautheny A; Duwat C; Aurégan G; Joséphine C; Hérard AS; Jan C; Mitja J; Gipchtein P; Gaillard MC; Buée L; Blum D; Hantraye P; Bonvento G; Brouillet E; Cambon K; Bemelmans AP
    Neurobiol Dis; 2021 Jul; 155():105398. PubMed ID: 34019997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TREM2 sustains microglial expansion during aging and response to demyelination.
    Poliani PL; Wang Y; Fontana E; Robinette ML; Yamanishi Y; Gilfillan S; Colonna M
    J Clin Invest; 2015 May; 125(5):2161-70. PubMed ID: 25893602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Triggering receptor expressed on myeloid cells 2 (TREM2) dependent microglial activation promotes cisplatin-induced peripheral neuropathy in mice.
    Hu LY; Zhou Y; Cui WQ; Hu XM; Du LX; Mi WL; Chu YX; Wu GC; Wang YQ; Mao-Ying QL
    Brain Behav Immun; 2018 Feb; 68():132-145. PubMed ID: 29051087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tanshinone I selectively suppresses pro-inflammatory genes expression in activated microglia and prevents nigrostriatal dopaminergic neurodegeneration in a mouse model of Parkinson's disease.
    Wang S; Jing H; Yang H; Liu Z; Guo H; Chai L; Hu L
    J Ethnopharmacol; 2015 Apr; 164():247-55. PubMed ID: 25666429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opposing roles of the triggering receptor expressed on myeloid cells 2 and triggering receptor expressed on myeloid cells-like transcript 2 in microglia activation.
    Zheng H; Liu CC; Atagi Y; Chen XF; Jia L; Yang L; He W; Zhang X; Kang SS; Rosenberry TL; Fryer JD; Zhang YW; Xu H; Bu G
    Neurobiol Aging; 2016 Jun; 42():132-41. PubMed ID: 27143430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TREM2 deficiency attenuates neuroinflammation and protects against neurodegeneration in a mouse model of tauopathy.
    Leyns CEG; Ulrich JD; Finn MB; Stewart FR; Koscal LJ; Remolina Serrano J; Robinson GO; Anderson E; Colonna M; Holtzman DM
    Proc Natl Acad Sci U S A; 2017 Oct; 114(43):11524-11529. PubMed ID: 29073081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual induction of TREM2 and tolerance-related transcript, Tmem176b, in amyloid transgenic mice: implications for vaccine-based therapies for Alzheimer's disease.
    Melchior B; Garcia AE; Hsiung BK; Lo KM; Doose JM; Thrash JC; Stalder AK; Staufenbiel M; Neumann H; Carson MJ
    ASN Neuro; 2010 Jul; 2(3):e00037. PubMed ID: 20640189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What happens to microglial TREM2 in Alzheimer's disease: Immunoregulatory turned into immunopathogenic?
    Lue LF; Schmitz C; Walker DG
    Neuroscience; 2015 Aug; 302():138-50. PubMed ID: 25281879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TREM2 deficiency impairs chemotaxis and microglial responses to neuronal injury.
    Mazaheri F; Snaidero N; Kleinberger G; Madore C; Daria A; Werner G; Krasemann S; Capell A; Trümbach D; Wurst W; Brunner B; Bultmann S; Tahirovic S; Kerschensteiner M; Misgeld T; Butovsky O; Haass C
    EMBO Rep; 2017 Jul; 18(7):1186-1198. PubMed ID: 28483841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TREM2 is upregulated in amyloid plaque-associated microglia in aged APP23 transgenic mice.
    Frank S; Burbach GJ; Bonin M; Walter M; Streit W; Bechmann I; Deller T
    Glia; 2008 Oct; 56(13):1438-47. PubMed ID: 18551625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.